Chennai

Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Technology and Operations services, and Accenture Song all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers.

Post : Drug Safety Associate

For more than six glorious decades, NLC India Limited has been a forerunner amongst the Public Sector Enterprises in the country in the energy sector, contributing to a lion's share in lignite production and significant share in thermal and renewable energy generation. The Company was incorporated on 14.11.1956. NLCIL is a Navratna Government of India Enterprise, under the administrative control of Ministry of Coal.

This Institute was established in the year from 1963 in IMPCOPS, Chennai with a motive to study the phyto-chemical aspects of medicinal plants in an around the city. Later Central Council for Research in Indian Medicine and Homeopathy had taken over this Institute as grant in aid. In the year of 1979, this institute became a part of Central Council for Research in Ayurvedic Sciences (formerly Central Council for Research in Ayurvedic and Siddha). This institute had diversified its activities to drug standardization besides phyto-chemical studies.

Karnataka Antibiotics and Pharmaceuticals Limited, KAPL Bengaluru is a Government of India Enterprise. Karnataka Antibiotics and Pharmaceuticals Limited is a Joint Sector Company of Government of India with shareholding from Government of Karnataka through Karnataka State Industrial Infrastructure Development Corporation KSIIDC. From a modest beginning in 1984, KAPL has grown exponentially in the areas of manufacturing and marketing of various life saving and essential drugs.

The Central Council for Research in Ayurvedic Sciences (CCRAS) is an autonomous body of the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy), Government of India. It is an apex body in India for the formulation, coordination, development and promotion of research on scientific lines in Ayurveda and Sowa-Rigpa system of medicine.

The Central Council for Research in Ayurvedic Sciences (CCRAS), an autonomous body under the Ministry of AYUSH, invites applications to fill up the following posts

Founded in 1849, Pfizer is the worlds premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Post : Key Account Manager

Bafna Pharmaceuticals forayed into the pharmaceutical manufacturing industry, way back in 1981 and consistent drive and determination of Mr. Bafna Mahaveer Chand to expand horizons resulted in the metamorphosis of Bafna Pharmaceuticals into a Public Limited Company in 1995.

Bafna Pharmaceuticals Limited is looking for experienced and competent professionals to be an integral part of our team for Formulation plant (MHRA) at Red hills, Chennai.

Biocon is global biopharmaceutical company changing patients lives in over 120 countries by finding new and affordable ways to treat diabetes, cancer and autoimmune diseases. Powered by advanced therapy platforms, our 12,000 plus employees blend heart, science and creativity to make better healthcare solutions. Biocons 4 global businesses include generics, biosimilars, research services and novel biologics. They represent Biocon’s risk-balanced strategy, underpinned by agile network connections, a robust pipeline and a timely emerging markets orientation.